Dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Pharmaceutics"
DOI: 10.1016/j.ijpharm.2022.121704
Abstract: Unpredictable outbreaks due to respiratory viral infections emphasize the need for new drug delivery strategies to the entire respiratory tract. As viral attack is not limited to a specific anatomic region, antiviral therapy that targets… read more here.
Keywords: lung; formulation; deposition; powder formulation ... See more keywords
The efficacy of different surface applications of wettable powder formulation of Detech® diatomaceous earth against the rice weevil, Sitophilus oryzae (L.) (Coleoptera: Curculionidae)
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Stored Products Research"
DOI: 10.1016/j.jspr.2020.101725
Abstract: Abstract In this study, the insecticidal activity of the wettable powder formulation of Detech® diatomaceous earth against the rice weevil, Sitophilus oryzae (Coleoptera: Curculionidae), an important stored grain pest, was investigated. Detech® diatomaceous earth was… read more here.
Keywords: detech diatomaceous; powder formulation; formulation detech; diatomaceous earth ... See more keywords
Dry powder formulation of azithromycin for COVID-19 therapeutics
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Microencapsulation"
DOI: 10.1080/02652048.2023.2175924
Abstract: Abstract Azithromycin is an antibiotic proposed as a treatment for the coronavirus disease 2019 (COVID-19) due to its immunomodulatory activity. The aim of this study is to develop dry powder formulations of azithromycin-loaded poly(lactic-co-glycolic acid)… read more here.
Keywords: dry powder; powder formulation; covid; powder ... See more keywords
Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance.
Sign Up to like & getrecommendations! Published in 2022 at "Endocrine journal"
DOI: 10.1507/endocrj.ej21-0656
Abstract: We describe a case of a 38-year-old woman who, after radioactive iodine therapy for Graves' disease, developed severe hypothyroidism despite receiving a high dose of levothyroxine (L-T4) tablet as replacement therapy. Her thyroid stimulating hormone… read more here.
Keywords: powder formulation; tablet; patient; hypothyroidism patient ... See more keywords